On the other hand, kinase-inactivating mutations in the FES gene have been detected in colorectal cancer cells (Bardelli et al. 2003; Sangrar et al. 2005), and low or absent FES expression has been reported in colon cancer specimens compared with matched normal tissues (Kanda et al. 2009). This evidence concerns the gene FES and colonic neoplasm.